BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29226953)

  • 1. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
    Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
    Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
    Aftab MN; Dinger ME; Perera RJ
    Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs as Key Players in the Management of Cutaneous Melanoma.
    Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on melanoma epigenetics.
    de Unamuno B; Palanca S; Botella R
    Curr Opin Oncol; 2015 Sep; 27(5):420-6. PubMed ID: 26197354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs role as potential biomarkers and key regulators in melanoma.
    Varamo C; Occelli M; Vivenza D; Merlano M; Lo Nigro C
    Genes Chromosomes Cancer; 2017 Jan; 56(1):3-10. PubMed ID: 27561079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
    Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
    Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pivotal MicroRNAs in Melanoma: A Mini-Review.
    Deng Z; Hao J; Lei D; He Y; Lu L; He L
    Mol Diagn Ther; 2016 Oct; 20(5):449-55. PubMed ID: 27351922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival.
    Sánchez-Sendra B; Martinez-Ciarpaglini C; González-Muñoz JF; Murgui A; Terrádez L; Monteagudo C
    Sci Rep; 2018 Nov; 8(1):17076. PubMed ID: 30459436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
    Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
    Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-153-3p suppress cell proliferation and invasion by targeting SNAI1 in melanoma.
    Zeng HF; Yan S; Wu SF
    Biochem Biophys Res Commun; 2017 May; 487(1):140-145. PubMed ID: 28400282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis.
    Ji SM
    Med Sci (Paris); 2018 Oct; 34 Focus issue F1():74-80. PubMed ID: 30403179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in the pathogenesis of renal cell carcinoma and their diagnostic and prognostic utility as cancer biomarkers.
    Fedorko M; Pacik D; Wasserbauer R; Juracek J; Varga G; Ghazal M; Nussir MI
    Int J Biol Markers; 2016 Feb; 31(1):e26-37. PubMed ID: 26481440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.
    Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H
    Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
    Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.